Challenges in medicine and healthcare are a global issue, particularly when it comes to the application of advanced science. Furthermore, the challenges are different across regions and countries. Additionally, when it comes to pharmaceutical development, or in other words, the number of clinical studies and trials directly related to treatment, the United States and Europe have a larger scale and a higher number of cases compared to Asia. As a result, despite Asia’s larger population and growing economy, its presence in healthcare and medicine remains relatively limited. Therefore, it is crucial to strengthen the system for training young and mid-career professionals—future leaders of Asia—at cancer treatment development centers, while also attracting talented personnel.
Through the Atlas Project, we aim to establish an international platform for conducting clinical research and trials in oncology across Asia, with a particular focus on treatment and the development of new therapeutic methods. Through the Atlas Project, we hope to establish top-tier cancer research and treatment centers as the foundation, improving the quality of research at institutions and across countries. At the same time, we aim to build a research network that enables efficient and high-performance studies on an international scale.
